Target intelligence / Profile preview

Mitochondrial respiratory chain complex I and II (Complex I/II)

Target
Complex I/II
Molecular classification
Enzyme, Oxidoreductase, Mitochondrial protein complex
01

Overview

Mitochondrial respiratory chain complexes I and II are essential components of the electron transport chain located in the inner mitochondrial membrane. Complex I (NADH:ubiquinone oxidoreductase) utilizes a flavin mononucleotide (FMN) cofactor to initiate electron transfer from NADH, while Complex II (succinate dehydrogenase) utilizes a flavin adenine dinucleotide (FAD) cofactor to transfer electrons from succinate (Hirst, J. Annu Rev Biochem, 2013; Cecchini, G. Crit Rev Biochem Mol Biol, 2003). These complexes are primary sites for the generation of reactive oxygen species (ROS) and are critical for maintaining the cellular energy balance through ATP production (Brand, M. D. Biochem Soc Trans, 2010). Dysfunction in these complexes is linked to a variety of conditions, including mitochondrial DNA disorders, neurodegenerative diseases like Parkinson's, and metabolic syndromes (Koopman, W. J. et al. N Engl J Med, 2012). In oncology, these complexes are targeted to disrupt the metabolic flexibility of cancer cells, with drugs like metformin and IACS-010759 acting as inhibitors that can interact with the flavin-containing subunits (Wheaton, W. W. et al. Nat Cell Biol, 2014; Molina, J. R. et al. Nat Med, 2018). However, targeting these complexes carries significant risks, such as lactic acidosis and systemic toxicity due to their fundamental role in cellular respiration (Owen, M. R. et al. Biochem J, 2000).

Other names
NADH:ubiquinone oxidoreductaseSuccinate dehydrogenaseNADH dehydrogenaseSuccinate-ubiquinone oxidoreductaseETC Complex IETC Complex II
02

Mechanism of action

Inhibition of electron transfer at the flavin-containing subunits (FMN in Complex I and FAD in Complex II) of the mitochondrial respiratory chain, leading to decreased ATP production and altered cellular redox state (Hirst, J. Annu Rev Biochem, 2013; Cecchini, G. Crit Rev Biochem Mol Biol, 2003).

03

Biological functions

Oxidative phosphorylationElectron transportATP synthesisReactive oxygen species generationMetabolic regulation
04

Disease associations

Mitochondrial diseaseCancerNeurodegenerative diseaseType 2 diabetesIschemia-reperfusion injury
05

Safety considerations

Lactic acidosisMitochondrial toxicityNeuropathyMyopathySystemic metabolic crisis
06

Interacting drugs

Metformin

6 more in the full profile.

07

Biomarkers

Lactate levelsOxygen consumption rate (OCR)Mitochondrial membrane potentialSuccinate levelsNADH/NAD+ ratio

Beyond the preview

Go deeper on Mitochondrial respiratory chain complex I and II (Complex I/II).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial respiratory chain complex I and II (Complex I/II).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call